One Million Served: Radiesse Reaches Milestone
Last week, spokespersons from Radiesse and Bioform Medical Inc. reported that 1 million syringes of Radiesse dermal filler have been shipped since ’02.
Radiesse being the staple product of Bioform, is most commonly used to fill nasolabial folds, wrinkles and correct facial lipoatrophy. The filler has been marketed for cosmetic and therapeutic use in Europe since 2002. In 2006 FDA approval for aesthetic facial treatments was granted in the United States, expanding Radiesse’ use beyond therapeutic treatments to include subdermal implantation.
At this time, about ten thousand cosmetic surgery and dermatology practices have used Radiesse – a landmark achievement that cements the company’s position as one of the global market leaders in cosmetic surgery products. The only comparable fillers with such widespread appeal are those made of collagen or hyaluronic acid, both of which have been on the market longer.